Skip to main content
ResMed10-Q: Inflation impact

ResMed cites inflation in product, freight, and overhead costs as a risk to margins.

What happened

The company is concerned that sustained inflationary pressures will adversely affect gross margins and operating results, creating a need for cost-control and efficiency solutions to protect profitability.

Source

SEC EDGARJan 29, 2026

Quarterly report (Form 10-Q)

ResMed 10-Q

Filing excerpt

Inflationary factors such as increases in the cost of our products, freight, overhead costs or wage rates may adversely affect our operating results.

sec.gov/Archives/edgar/data/943819/000094381926000007/rmd-20251231.htmRead the full source

Other signals in this filing (11)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Inflation impact

What this signalsFilings often name leadership changes, deals and spending plans.

Filed
Jan 29, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Details

CIK
943819
Accession number
0000943819-26-000007
Timeframe
Current quarter
Filing year
2026
Fiscal year
0
Why it matters
Efficiency tools needed
Signal category
Operations

Extraction

Confidence
High
Relevance
70%
Sentiment
Negative
Detected
Feb 3, 2026
signal_type
sec-10q
signal_subtype
inflationImpact

Use this data

Get every 10-Q signal for ResMed and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at ResMed this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/627bfa9b-fd8c-45eb-859e-9e5a67166078 returns this record as JSON. POST /v1/companies/enrich returns every signal for resmed.com.

{
  "signal_id": "627bfa9b-fd8c-45eb-859e-9e5a67166078",
  "signal_type": "sec-10q",
  "signal_subtype": "inflationImpact",
  "detected_at": "2026-02-03T08:37:20.04+00:00",
  "company": {
    "name": "ResMed",
    "domain": "resmed.com"
  },
  "data": {
    "detail": "The company is concerned that sustained inflationary pressures will adversely affect gross margins and operating results, creating a need for cost-control and efficiency solutions to protect profitability.",
    "metrics": {
      "timeframe": "current_quarter"
    },
    "summary": "ResMed cites inflation in product, freight, and overhead costs as a risk to margins.",
    "excerpts": "Inflationary factors such as increases in the cost of our products, freight, overhead costs or wage rates may adversely affect our operating results.",
    "relevance": 0.7,
    "sentiment": "negative",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/943819/000094381926000007/rmd-20251231.htm",
    "filing_date": "2026-01-29",
    "filing_year": 2026,
    "fiscal_year": 0,
    "sales_relevance": "Efficiency tools needed",
    "signal_category": "operations"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.